Table 2.
Number of unique eccDNA with same chromosomal coordinates allowing 200 basepairs + /- overlap in both start and end eccDNA coordinate.
| Cell line | Replicate 1 + 2 | Replicate 1 + 3 | Replicate 2 + 3 | Replicate 1 + 2 + 3 | eccDNA coordinate commonality in 2 replicatesa | eccDNA coordinate commonality in 3 replicatesa |
|---|---|---|---|---|---|---|
| Mouse cancer cell lines: | ||||||
| MCA3D | 641 | 279 | 294 | 4 | 0.3% | 0.003% |
| PDV | 99 | 133 | 225 | 1 | 0.2% | 0.001% |
| HaCa4 | 10 | 4 | 9 | 0 | 0.1% | 0.000% |
| CarC | 81 | 72 | 100 | 2 | 0.2% | 0.004% |
| Human cancer cell lines: | ||||||
| AsPC-1 | 156 | 150 | 99 | 2 | 0.2% | 0.002% |
| MIA-PaCa-2 | 407 | 332 | 532 | 1 | 0.2% | 0.001% |
| PC-3 | 46 | 50 | 48 | 9 | 0.2% | 0.034% |
a
Percent average of the total number of unique eccDNA/number of eccDNA that has the same chromosomal coordinates in either two or three replicates (+/- 200 basepairs).